Navigation Links
Human Genome Sciences Submits Biologics License Application to FDA for ABthrax(TM)
Date:5/21/2009

- First-in-class treatment for inhalation anthrax -

ROCKVILLE, Md., May 21 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for its human monoclonal antibody drug ABthrax(TM) (raxibacumab) for the treatment of inhalation anthrax.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO )

The BLA submission includes the results of two randomized placebo-controlled studies conducted in rabbits and monkeys to evaluate the efficacy of raxibacumab. These studies showed a survival benefit in two relevant animal species, which is the requirement for establishing the efficacy of new drugs used to counter bioterrorism. The submission also includes the results of safety studies of raxibacumab conducted in healthy human volunteers.

"Based on the results of our efficacy and safety studies, we believe raxibacumab has the potential to be an important new treatment for inhalation anthrax," said Sally D. Bolmer, Ph.D., R.A.C, Senior Vice President, Development and Regulatory Affairs, HGS. "In addition, the raxibacumab BLA is the first HGS has submitted, so it represents a significant milestone for our Company."

Raxibacumab is a first-in-class treatment for anthrax, and is being developed under a contract entered into in 2006 with the Biomedical Advanced Research and Development Authority (BARDA) of the Office of the Assistant Secretary for Preparedness and Response (ASPR), U.S. Department of Health and Human Services (HHS).

In the first quarter of 2009, under t
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. Enrollment Begins on Human PK Study for Medidur(TM) FA
4. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
5. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
8. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
9. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
10. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Aug. 20, 2014 Reportlinker.com announces ... available in its catalogue: Personal ... Trends and Opportunities to 2018 ... The report provides in depth market analysis, ... accident and health insurance segment, including: - ...
(Date:8/20/2014)... 2014 Reportbuyer.com has added a new market ... https://www.reportbuyer.com/product/98394/Global-Cardiac-Defibrillators-Industry.html This report analyzes ... by the following Product Segments: Implantable/Internal Cardiac Defibrillators, and ... the US, Canada , ... Asia-Pacific , Middle East ...
(Date:8/20/2014)... RANCHO MIRAGE, Calif. , Aug. 20, 2014 ... patient named Fernando Davila has been successfully treated ... eating disease", by Dr, Anibal R. Gauto , Medical ... Care Center, at Eisenhower Medical Center in Rancho ... a new treatment pioneered by Dr. John Crew ...
Breaking Medicine Technology:Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 2Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 3Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 4Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 5Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 6Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 7Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 8Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 9Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 10Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 11Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 12Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 13Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 14Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 15Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 16Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 17Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 18Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 19Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 20Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 21Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 22Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 23Global Cardiac Defibrillators Industry 2Global Cardiac Defibrillators Industry 3Global Cardiac Defibrillators Industry 4Global Cardiac Defibrillators Industry 5Global Cardiac Defibrillators Industry 6Global Cardiac Defibrillators Industry 7Global Cardiac Defibrillators Industry 8Global Cardiac Defibrillators Industry 9Global Cardiac Defibrillators Industry 10Global Cardiac Defibrillators Industry 11Global Cardiac Defibrillators Industry 12Global Cardiac Defibrillators Industry 13Global Cardiac Defibrillators Industry 14
... Cetrorelix showed good safety and tolerability profile ... level,Japanese partner Shionogi initiates Phase 2b trial, ... AEterna,Zentaris Inc. along with its Japanese partner ... for a Phase 2a trial with,cetrorelix in ...
... WIRE)--Mar 22, 2007 - Nutra Pharma,Corp. (OTCBB: ... for HIV and Multiple Sclerosis has today ... received notification of,acceptance of its paper for ... conference issue., The article, entitled "Alpha-Cobratoxin as ...
Cached Medicine Technology:AEterna Zentaris Reports Positive Results with Cetrorelix in BPH,for Japanese Phase 2a Trial 2AEterna Zentaris Reports Positive Results with Cetrorelix in BPH,for Japanese Phase 2a Trial 3AEterna Zentaris Reports Positive Results with Cetrorelix in BPH,for Japanese Phase 2a Trial 4Nutra Pharma Announces Publication of Research on Treatment for,Multiple Sclerosis 2Nutra Pharma Announces Publication of Research on Treatment for,Multiple Sclerosis 3
(Date:8/21/2014)... mynt welcomes industry leaders Rob and Tiffanie ... growing company. Since its pre-launch in April, mynt has ... continues to gain momentum leading up to its official ... came into network marketing by chance. Tiffanie worked for ... marketing companies. Tiffanie needed help at one particular distributor ...
(Date:8/21/2014)... August 21, 2014 According to ... Application (Biodegradable polymer, Food & Beverage, Personal care ... (Packaging, Agriculture, Automobile, Electronics, Textile) & Geography - ... lactic acid and polylactic acid markets and segments ... each market, based on their sub-segments, in terms ...
(Date:8/21/2014)... Luis Obispo, CA (PRWEB) August 21, 2014 ... edition of Current Pedorthics, a bi-monthly publication of the Pedorthic ... field of pedorthics. , Bunion Bootie ... an alternative solution for bunion sufferers and their pain. It ... worn in nearly any shoe to eliminate the friction and ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 While golfing ... found it hard to stay focused on his game ... mosquitoes. The constant whine, slapping and continual need to ... innovative methods to stay protected from insects while golfing. ... career in the Financial Services/Investment Banking Industry, decided to ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 Atlantic Information ... of ACO Business News and The AIS Report on ... the Blue Cross Blue Shield Association or its member ... the latest report in AIS’s Management Insight Series. ... case studies of two insurers — Horizon Healthcare Services, ...
Breaking Medicine News(10 mins):Health News:Industry Leaders Rob and Tiffanie Moffitt Join mynt 2Health News:Lactic Acid Market Worth $3,577.5 Million & Polylactic Acid Market Worth $4,840.1 Million by 2019 – New Report 2Health News:Lactic Acid Market Worth $3,577.5 Million & Polylactic Acid Market Worth $4,840.1 Million by 2019 – New Report 3Health News:Recently Featured in Current Pedorthics: Bunion Bootie, the Very Popular Bunion Treatment Splint 2Health News:Recently Featured in Current Pedorthics: Bunion Bootie, the Very Popular Bunion Treatment Splint 3Health News:Financial VP Fights Pesky Bugs with Launch of Biteback Sports Insect Shield® Golf Apparel 2Health News:New AIS Report Highlights Two Case Studies of Bundled Payment Models 2
... HealthDay Reporter , MONDAY, Nov. 22 (HealthDay News) -- Children ... risk for experiencing a stroke compared with those whose parents, ... The finding stems from a survey of more than 13,000 ... when they were young children or adolescents. "I certainly ...
... mouse is helping researchers learn whether more muscle improves ... looking for ways to counteract the unhealthy effects of ... Medical College of Georgia Vascular Biology Center and co-director ... Obesity increases the risk for cardiovascular disease as well ...
... patients whose treatment is delayed not only become sicker than ... dollars more in care over the first several years of ... get people into care early because they will stay healthier ... M.D., M.P.H., an associate professor of medicine in the Division ...
... , MONDAY, Nov. 22 (HealthDay News) -- The pain of ... foot, elbow and lower back pain, a new study has ... osteoarthritis (OA) patients, aged 45 to 79, about pain in ... ankle or foot. Low back pain was significantly associated ...
... known for his groundbreaking work in biochemistry, received the ... joins an illustrious list of laureates which includes 15 ... his research related to artificial leaves and its creation ... research. This Medal has been awarded since 1921 to ...
... SATURDAY, Nov. 20 (HealthDay News) -- Kidney failure patients ... prescribed had significantly better heart function, overall health and ... finding stems from an analysis that compared the impact ... treatments per week, for three to four hours per ...
Cached Medicine News:Health News:Children of Divorce Face Twice the Lifetime Risk of Stroke: Study 2Health News:Children of Divorce Face Twice the Lifetime Risk of Stroke: Study 3Health News:Fat yet muscular mouse provides clues to improving cardiovascular health 2Health News:For HIV-positive patients, delayed treatment a costly decision 2Health News:Top Swedish scientist professor Bertil Andersson awarded prestigious Wilhelm Exner Medal in Vienna 2Health News:Top Swedish scientist professor Bertil Andersson awarded prestigious Wilhelm Exner Medal in Vienna 3Health News:Top Swedish scientist professor Bertil Andersson awarded prestigious Wilhelm Exner Medal in Vienna 4Health News:Top Swedish scientist professor Bertil Andersson awarded prestigious Wilhelm Exner Medal in Vienna 5Health News:Doubling Frequency of Dialysis May Help Kidney Failure Patients 2Health News:Doubling Frequency of Dialysis May Help Kidney Failure Patients 3
Inquire...
BD Vacutainer® Plus Plastic Serum Tubes have spray-coated silica and are used for serum determinations in chemistry, serology, and immunohematology....
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
The inner wall of the tube is coated with spray-dried lithium, ammonium or sodium heparin. These additives are anti-coagulants, which activate anti-thrombins, thus blocking the coagulation cascade of...
Medicine Products: